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ABSTRACT

CHANGES IN CORTICAL ACTIVITY IN STROKE STURVIVORS UNDERGOING
BOTULINUM TOXIN THERAPY FOR TREATMENT OF FOCAL SPASTICITY

Kelsey Tynes, B.S.
Marquette University, 2018

Functional magnetic resonance imaging (fMRI) has provided evidence of
neuroplastic changes following rehabilitation in stroke survivors. Botulinum toxin
(BoNT) injection therapy has become a common approach to combating spasticity—a
motor disorder characterized by a velocity dependent increase in muscle tone. The
neurotoxin acts to inhibit muscle contraction, relieving spasticity symptoms with peak
effects occurring between 4 and 6 weeks. With decreases in muscle tone, BoNT
injections could free arm movement for rehabilitation, creating the opportunity for
enhanced control of the upper limb, which would have underpinnings in altered brain
activity. Given evidence of cortical activation changes following other stroke
rehabilitative methods, it is expected that BoNT therapy would produce similar types of
changes. The aim of this study was to quantify changes in task-related activity throughout
the brain in stroke survivors undergoing BoNT therapy. Understanding the changes in
cortical activity resulting from BoNT injections could help improve rehabilitation
methods and predict functional outcome.
Changes in cortical activation in response to BoNT injections have only been
documented in a handful of studies. Of these past studies, participant pools tended to
include patients with moderate to high functional ability of the affected limb. Although
patients receiving BoNT injections often fall within a wide range of severity, BoNT
injections have been shown to provide the biggest impact on the highly impaired
population. BoNT injections have also been shown to provide greatest effects during the
initial injections, and the effects on long-term spasticity treatment are less prevalent in the
literature.
In this study, we used a voxel-based approach to quantify neuroplastic effects and
capture changes in activity throughout the brain, including regions outside the primary
sensorimotor cortices. We recruited a majority of participants that presented with severe
spasticity, who were scheduled to receive a round of BoNT injections as part of their
standard of care. By assessing the brain activation associated with repeated injections, we
obtained insight into BoNT on a long-term basis, as it is traditionally prescribed.
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CHAPTER 1: INTRODUCTION AND BACKGROUND TO POSTSTROKE
SPASTICITY MANAGEMENT AND MRI TECHNIQUES

1.1 MOTOR RECOVERY FOLLOWING STROKE: EFFECTS AND SOLUTIONS TO
POSTSTROKE SPASTICITY
To most of the world’s population, tasks such as bathing, dressing, and exercise
come as a standard to any daily routine. To an individual experiencing spasticity,
however, each of these tasks could require some effort and at times assistance.
Approximately 3 in 5 stroke survivors experience spasticity—of those, only half seek
treatment to relieve symptoms (Urban et al., 2010).
Treatments and rehabilitation measures are prescribed depending on severity and
comfort level of the patient. A method of spasticity treatment implemented in medical
clinics is Botulinum-toxin A (BoNT) injection therapy. These injections are applied to
affected spastic limbs and are intended to aide in relaxing the hyperactive muscle. The
injections can be used for reasons related to pain management, hygiene, ease of care, and
activities of daily living.
Botulinum-toxin A injection therapy has been a technique for managing spasticity
symptoms for decades; however, the understanding behind its effects on neuronal activity
in the brain is limited. Efforts to understand the underlying effects of BoNT therapy on
functional motor recovery and its effects on associated neuronal activity are believed to
have the potential to help further develop clinical therapies. A handful of studies have
assessed cortical activation of stroke survivors’ naïve to BoNT injections, which have
showed varying results (Bergfeldt, Jonsson, Bergfeldt, & Julin, 2015; Diserens et al.,
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2010; Manganotti et al., 2010; Senkárová, Hlustík, Otruba, Herzig, & Kanovský, 2010;
Tomášová et al., 2013; Veverka et al., 2014, 2016, 2012). This study aims to quantify
changes in functional activity of stroke survivors undergoing BoNT injection therapy as a
standard practice of care, adding to the limited knowledge on the topic. This chapter
discusses the causes of spasticity and how BoNT therapy works to counter its disabling
effects, and outlines the benefits of fMRI to quantify the effects of BoNT on a neuronal
level.

1.1.1

Stroke
Stroke is the fifth leading cause of death in the United States, affecting

approximately 795,000 people each year (Benjamin et al., 2018). A stroke can occur by
two different means and is categorized by type (Gomes & Wachsman, 2013). An
ischemic stroke occurs when a clot forms within the brain’s blood vessels or travels from
elsewhere in the body to form a blockage within the brain’s blood supply. When blood
supply is cut off, the region is deprived of oxygen and brain cells quickly die. A
hemorrhagic stroke is the result of a ruptured vessel in the brain, most commonly caused
by high blood pressure or an aneurysm (Donnan, Fisher, Macleod, & Davis, 2008). In
both cases, the outcome following stroke often results in reduced physical condition and
capability.
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1.1.2

Spasticity

OVERVIEW

Spasticity is a chronic stretch reflex disorder characterized by increased muscle
tone in upper and/or lower extremities, most commonly caused by damage to a portion of
the brain or spinal cord. This is a velocity-dependent disorder, which causes increased
resistance when a muscle group is passively stretched. It is emphasized that spasticity is
merely one component of the upper motor neuron syndrome (UMNS) (Lance et al.,
1980). EMG recordings during passive stretch show increased activity with increased
velocity, with a delayed effect where the muscle continues to contract even after
movement has ended. This suggests the hypertonia occurs by two means: hypertonia
elicited by the stretch reflex (spasticity), and hypertonia elicited by muscle contracture
(intrinsic hypertonia) (Galiana, Fung, & Kearney, 2005; Dietz &Berger, 1983).
Affecting over 12 million people worldwide, hypertonia can be seen by the
physical manifestation of a tight fist, flexed elbow, and an arm pressed against the chest
(Nair & Marsden, 2014). These permanent contractions can become painful and hinder
overall muscle movement and coordination, causing difficulties with everyday activities
(Benjamin et al., 2018).

NEURAL MECHANISMS

Neural Basis of Motor Impairment
Lesions that occur in the gray matter of the primary motor cortex (M1) or damage
the white matter fibers comprising the corticospinal tract (CST) are most likely to cause
gross motor impairment (Maraka et al., 2014). Infarcts localized to the pons, cerebellum,
thalamus, or association areas can often hinder fine motor movements (Darling et al.,
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2011). Voluntary motor actions are mediated both by direct and indirect anatomical
pathways. Simple motor tasks (single muscle or joint) are largely controlled by
pyramidal cells in the M1, which elicit movement at low stimulation thresholds by
projecting to motoneurons in the spinal cord. Planning of more intricate patterns is often
produced by premotor areas, which project to both the M1 and spinal cord in order to
produce the physical movement (Rizzolatti, Fadiga, Gallese, & Fogassi, 1996).
Stimulation and damage to these areas have provided extensive evidence supporting their
involvement in movement.

Neural Basis of Spasticity
In healthy subjects, the stretch reflex acts to resist the lengthening of a muscle.
This process is mediated by excitatory connections between Ia afferent fibers stemming
from muscle spindles and alpha-motoneurons innervating the same muscle (Trompetto et
al., 2014). By passively stretching a muscle, the firing rate increases in the Ia spindle
fiber, leading the Ia fibers to fire and send signals to the alpha motoneurons through
monosynaptic pathways, resulting in contraction of the original muscle and relaxation of
its antagonist (Figure 1.1) (Pearson & Gordon, 2000).
The exact mechanism behind spasticity’s exaggeration of the stretch reflex is still
unclear today. The disorder could theoretically be caused by two different factors:
increased excitability of Ia afferents stemming from the muscle spindles, or abnormal
processing of sensory inputs from muscle spindles creating excessive reflex activation of
the alpha-motoneurons (Trompetto et al., 2014).
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Figure 1.1: Stretch Reflex Pathway. This diagram illustrates the monosynaptic
pathways that mediate the stretch reflex, indicating the primary neurons involved
(Pearson & Gordon, 2000).

LIMITATION OF FUNCTION AND IMPACT ON THERAPY

Therapeutic interventions become necessary when spasticity symptoms begin to
interfere with daily living (Levin & Hui-Chan, 1992). Upper-limb spasticity can often
make tasks such as reaching, grasping, and releasing objects difficult (Francisco &
McGuire, 2012). Early management of spasticity can often lead to improved motor
recovery outcomes (Thompson, Jarrett, Lockley, Marsden, & Stevenson, 2005).
Rehabilitation plans tend to break down to three main categories: improving
movement, improving daily life activities, and improving quality of life. Improving
movement focuses on unmasking voluntary movements and recovering damaged neural
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circuits by practicing motor plans. Improving daily life tends towards getting around,
dressing, and personal hygiene. Quality of life focuses on regaining an independent
lifestyle and possible reintegration into the workplace (Gracies, Elovic, McGuire, &
Simpson, 1997).

1.1.3

Neural Plasticity Following Stroke
While neural plasticity is most promising during developing stages of the brain,

changes in structural and functional integrity have been seen in stroke survivors during
the course of recovery. Alpha-motoneurons have been known to release growth factors
locally following traumatic injury (Weidner, Ner, Salimi, & Tuszynski, 2001). As these
neurons grow and spread, they form new synapses between interneurons and the severed
motoneurons, creating new pathways to replace the nonfunctional ones (Raineteau &
Schwab, 2001). Additionally, alternative descending pathways could be recruited to take
over motor drive to compensate for loss of corticospinal pathways. The excitatory
pathways descending from the brainstem tend to be less selective, resulting in over-active
muscle contractions (Trompetto et al., 2014).
Post-stroke studies have used structural (Schaechter, Perdue, & Wang, 2008;
Stinear et al., 2007) and functional (Johansen-Berg et al., 2002; Ward, Brown,
Thompson, & Frackowiak, 2003) imaging to document neuroplastic effects in both
ipsilesional and contralesional areas of the primary motor cortices. Studies have been
advancing into evaluation of the impact of therapeutic interventions on imaging data,
which have also shown promising results.

7
Functional MRI (fMRI) has been used to show a correlation between favorable
motor recovery following therapy and increased activity in the contralesional M1 during
motor tasks in chronic stages of stroke (Jones et al., 2015). Additional changes in activity
have been seen in motor areas of the brain following pedaling activity (Promjunyakul,
Schmit, & Schindler-Ivens, 2015), constraint-induced movement therapy (Schaechter et
al., 2002), and mirror therapy techniques (Michielsen et al., 2011).

1.2 BOTULINUM TOXIN-A INJECTION THERAPY
Several treatments are suggested for those affected by spasticity including
physical therapy, oral medication, injectable neurolytic medications, and surgical
procedures. Physical therapy often includes stretches and range of motion exercises,
which may be paired with more invasive options such as peripheral nerve blocks or
botulinum toxin injections. Botulinum toxin-A injections are a common treatment to
relieve spasticity experienced by stroke survivors. The toxin is injected directly into the
overactive muscle, and acts by preventing the release of neurotransmitters required to
elicit muscle contraction. Patients typically receive injections every 3-4 months to
manage symptoms.

1.2.1

History
Botulinum-toxin is produced by the motile bacterium Clostridium botulinum; the

toxin was first discovered in 1897 after rancid ham caused symptoms of botulism in
several guests attending a funeral. Emilie van Ermengem worked as a professor of
bacteriology and the University of Ghent, and discovered the agent responsible for the
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illnesses, initially naming it Bacillus botulinum (Devriese, 1999). In 1946, the toxin had
been purified and produced in mass quantities by researcher Edward Schantz. Nearly
twenty years later, botulinum toxin injections were found to induce paralysis and atrophy
when administered to muscles in a chick embryos (Drachman, 1964).
This finding fueled extensive research into many movement and autonomic
disorders, leading to various animal models to assess pain and mobility. The involvement
of BoNT in pain modulation was assessed using primarily mouse and rat models,
evaluating peripheral inflammatory pain (Cui, Khanijou, Rubino, & Aoki, 2004), visceral
pain (Chuang, Yoshimura, Huang, Chiang, & Chancellor, 2004), and neuropathic pain
(Bach-Rojecky, Relja, & Lacković, 2005). All results supported the notion that BoNT
could vastly reduce pain caused by several neurological conditions. Effects of BoNT on
the gastrocnemius muscle of mice showed that significantly decreased gastrocnemius
muscle stiffness during passive stretching (Haubruck et al., 2012). A study involving
injections to the masseter muscle of rabbits found that EMG activity of the muscle was
immediately reduced, demonstrating BoNT’s paralytic effects (Park et al., 2015).
Though animal models are continuing to grow in complexity, their initial results
motivated further research. Ophthalmologist Alan B. Scott theorized the toxin’s musclerelaxing effects might help treat crossed eyes. His group went on to treat monkeys with
BoNT-A for strabismus in the 1960s, and successfully translated the study to humans in
1981 (Scott, 1981). This pioneering study sparked research in therapeutic applications of
BoNT, including, but not limited to, cervical dystonia, migraine, and spasticity.
Human trials testing the safety and effectiveness of BoNT-A as a therapeutic
agent for managing post-stroke spasticity symptoms began in 1996 when Simpson
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demonstrated the effects of three different doses as compared to a placebo group.
Evaluated at two, four, and six weeks post-injection, all BoNT groups showed better
outcomes than placebo (Simpson et al., 1996). This protocol and those similar have been
repeated by many, resulting in FDA approval for Botox® in 2010. The effects of this
therapy have been extensively reviewed and the technique is continuously growing in
practice.

1.2.2

Cellular Mechanisms
In preparation of muscle contraction, presynaptic neuromuscular nerve endings

contain vesicles storing the neurotransmitter Acetylcholine (ACh). The nerve action
potential initiates the fusion of the vesicle to the nerve membrane, leading to the release
of ACh into the nerve synapse. Here ACh is able to bind to receptors on the muscle, and
elicit muscle contraction (Kuo & Ehrlich, 2015). The fusion process between
neurotransmitter-containing vesicles and presynaptic nerve membrane is facilitated by a
group of proteins forming the SNARE complex (Rossetto, Pirazzini, & Montecucco,
2014).
The BoNT molecule is comprised of two parts: a heavy chain (H-chain) and a
light chain (L-chain). The two chains are bound together by a disulfide bond and
protected by a protein coating. After injection, the molecule dissociates from the protein
and the H-chain binds to receptors on motor and sensory neuron nerve endings. The
entire complex is then pulled into the cell by endocytosis (Pickett, 2009). Here, the Lchain is released into the presynaptic cell cytoplasm. In motor neurons, the L-chain acts
by cleaving SNAP-25, an essential component of the SNARE complex (Söllner et al.,
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1993). Without a functional SNARE complex, the vesicles cannot release ACh, and
muscle contraction cannot occur (Figure 1.2). Similarly, in sensory neurons, the L-chain
is believed to act on SNAP-25 in a similar fashion. This blocks the release of
neuropeptides, inhibiting the sensitization of pain nerves (J. Park & Park, 2017). BoNT is
not believed to affect nerve conduction nor the synthesis of ACh, but simply hinders the
mechanisms essential for release.

Figure 1.2: Molecular Action of BoNT. The diagram serves as a flowchart starting at
the introduction of BoNT to the muscle tissue. Illustrated is the neurotoxin’s uptake from
the synaptic cleft and release into the presynaptic motor neuron, cleavage of SNAP-25
and inhibition of ACh release (Saravanan, Rajaseger, Eric, & Moochhala, 2015).
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1.3 FUGL MEYER ASSESSMENT
The Fugl-Meyer Assessment (FMA) is an index measured specifically in stroke
populations to quantify motor impairment (Fugl-Meyer, Jääskö, Leyman, Olsson, &
Steglind, 1975). The motor score portion of the test includes evaluations of movement,
coordination, and reflexes in both upper and lower extremities. In clinical settings FMA
is a common score used to determine impairment severity and predict motor recovery.
Scoring is based on a scale of 0 to 2 for each motion, 0 equating to total hemiplegia and 2
indicating normal motor performance.
Motions of the upper extremity motor test include reflex activity, flexor synergy,
extensor synergy, movements combining synergies, and movement out of synergy. The
wrist is tested for stability, flexion, extension and circumduction in varying combinations
of elbow and shoulder positions. The hand is assessed for mass finger flexion and
extension, along with various grasping tasks. Coordination and speed of a finger-to-nose
task compares affected and unaffected limbs to quantify impairment in dysmetria, tremor,
and speed. The upper extremity FM motor test has a maximum score of 66.
The FMA has been shown to have excellent validity and shows concurrence with
other accredited stroke motor scores, while providing a more detailed review of motor
ability. The scoring system has appraised for its inter- and intra-tester reliability and
construct validity (Gladstone, Danells, & Black, 2002). A clear correlate between
spasticity severity and decreased FMA scores has been found and confirmed by several
researchers (Katz, Rovai, Brait, & Rymer, 1992; Opheim, Danielsson, Alt Murphy,
Persson, & Sunnerhagen, 2015).
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1.4 MAGNETIC RESONANCE IMAGING (MRI)
1.4.1

MRI Signal
The MRI signal is derived from the precession and relaxation of hydrogen protons

in the presence of a large magnetic field. Each hydrogen atom consists of a single proton
that, when exposed to a static magnetic field (B0), aligns with the field and precesses
about its own axis at a frequency known as the Larmor frequency. With all protons
aligned together, their angular momentums sum to form a net magnetization (M0) in the
direction of B0. When an external radio-frequency (RF) pulse is administered at the
Larmor frequency, these protons are tipped from their low-energy state, now uniform in
both phase and direction (Haacke, Brown, Thompson, & Venkatesan, 1999).
Two phenomena are observed as the protons relax back to their static field state.
The longitudinal magnetization (Mz) is the portion of M0 seen parallel to the magnetic
field. Following the RF pulse, protons realign with B0, and Mz approaches its initial value
of M0. In addition, the phase-locked protons also disperse with respect to the x-y plane,
contributing to a transverse magnetization (Mxy) or the portion of M0 seen perpendicular
to the magnetic field. This is the signal measured by the MR receive coil (Haacke et al.,
1999).
Mz regrowth and Mxy decay correspond to T1 and T2 relaxation times
respectively. These variables are distinctive to each biological material, allowing for
unique MRI pulse sequence designs tailored to any given application. T1 weighted
images, characterized by the rate at which protons return to equilibrium along the B0
field, are often used to obtain a high resolution anatomical image to be used in
diagnostics. T2 and T2* together describe the transverse relaxation. The T2 signal
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describes the decay observed in spin-echo measurements and is related to the spin-spin
interactions as the protons dephase. Because the natural T2 relaxation cannot be
measured directly, the T2* or effective T2 signal, is measured using gradient-echo
sequences and is susceptible to changes in local magnetic fields (i.e. changes due to
increased/decreased blood flow). The T2* signal gives rise to additional analyses of MRI
results, such as the BOLD contrast method used with fMRI data (Huettel, Song, &
McCarthy, 2009).

1.4.2

BOLD Signal
MRI technology is capable of providing much more than anatomical data. The

T2* signal has been shown to be sensitive to oxygenation of the blood—the foundation of
functional MRI (Ogawa, Lee, Kay, & Tank, 1990). In the presence of a gradient-spinecho sequence, the paramagnetic properties seen in deoxyhemoglobin provide a natural
contrast in the MR image, and is said to be blood oxygen level dependent (BOLD).
BOLD contrast is the most common way to study local changes in brain
activation during a particular task. The paramagnetic properties of deoxygenated
hemoglobin tend to suppress the MRI signal, while diamagnetic properties of oxygenated
hemoglobin do not show this effect (Lindquist, Meng Loh, Atlas, & Wager, 2009).
During the initial moments of performing a mental task, deoxygenated
hemoglobin is high in concentration as neuronal activity is consuming ATP. As
metabolic demands increase, the vessels dilate to increase blood flow and oxygenated
blood is delivered to the active areas in need. This continues for about 4-8 seconds to
ensure the active area is supplied with enough oxygen. As demand decreases, blood flow
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is reduced while the active area consumes the remaining oxygen, and deoxygenated
hemoglobin again becomes high in concentration before returning to resting state
conditions (Figure 1.3) (Kim & Ogawa, 2012).

Figure 1.3: HDR Model. The standard model for the hemodynamic response function,
illustrating the primary fluctuations over time (initial dip at stimulus onset, primary
response window, negative overshoot following the end of mental task) (Kornak, Hall, &
Haggard, 2011)

The BOLD technique takes advantage of this varying MRI signal and allows
researchers to assess brain activity by measuring areas that follow the pattern
characterized by a modeled hemodynamic response function (HRF).

1.5 SPECIFIC AIM
The aim of this study was to determine changes in cortical activation patterns of
stroke survivors over the course of a single round of BoNT injections to the upper
extremity. These results could produce helpful insight into the effects of BoNT on motor
recovery and improve physical therapy interventions to best suit each patient.
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CHAPTER 2: CHANGES IN CORTICAL ACTIVITY IN STROKE SURVIVORS
UNDERGOING BOTULINUM TOXIN THERAPY FOR TREATMENT OF FOCAL
SPASTICITY

2.1 INTRODUCTION
The purpose of this study was to identify changes in brain activation associated
with hand movement following botulinum toxin-A (BoNT) injections to the upper
extremity as treatment for focal spasticity. Previous studies have documented varying
results regarding changes in brain activation in response to finger tapping and
flexion/extension of the hand in patients undergoing BoNT therapy. Prior to injection,
most studies have reported extensive bilateral activation of primary sensorimotor and
supplementary motor areas during movement of the affected hand (Manganotti et al.,
2010; Senkárová et al., 2010; Tomášová et al., 2013; Veverka et al., 2012). Activity
patterns following BoNT intervention decrease in active volume in primary motor areas,
demonstrating a localizing and lateralization effect (Bergfeldt et al., 2015; Manganotti et
al., 2010; Tomášová et al., 2013; Veverka et al., 2014). Other studies have shown
increases in activity in similar motor areas, along with increased activity in higher-order
motor areas such as the cerebellum, thalamus, anterior cingulate gyrus, among others
(Diserens et al., 2010; Tomášová et al., 2013; Veverka et al., 2016). These studies have
mainly included participants with finger movement ability, even before botulinum
injection. In people experiencing more severe impairments, BoNT injections could free
arm movement through the reduction of spastic restraint, creating the opportunity for
enhanced control of the upper limb (Park et al., 2017). In these cases, botulinum toxin
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treatment could result in widespread activation of brain areas as patients access motor
control networks for hand movement. In this study, we hypothesized that when BoNT is
used to free arm movements, higher-order areas of the brain such as motor planning and
sensory association areas would increase in activity during movement of the hand.
Our approach in this study was to examine changes in brain activation using
functional magnetic resonance imaging (fMRI) in participants with a wide range of upper
extremity impairment. Past studies have documented changes in cortical activity patterns
following BoNT injections in post-stroke participants performing sequential finger
patterns and flexion/extension of the hand—tasks that require substantial control of the
finger muscles (Bergfeldt et al., 2015; Manganotti et al., 2010). In order to determine
whether releasing spasticity of the arm using BoNT enhances higher-order brain function,
we targeted fMRI measurements in participants with limited hand function prior to
injection. An assistive device was created to aid in finger extension while in the scanner
and ensure that the task comprised an actual movement. This approach allowed
observation of the neurotoxin effect in a severely impaired test group, who have
traditionally benefitted most from the injections (Welmer, Holmqvist, & Sommerfeld,
2010).
As BoNT works to relieve spasticity, the muscle relaxes to an extent that allows
the patient to practice a wider range of motion. Functional recovery of a spastic limb
may be limited by the severity of the stroke, but BoNT injection therapy has proven to be
a safe and effective method to manage spasticity symptoms and help patients regain
functionality of the impaired limb (Hesse, Brandi-Hesse, Bardeleben, Werner, & Funk,
2001; Lagalla, Danni, Reiter, Ceravolo, & Provinciali, 2000; Slawek, Bogucki, &
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Reclawowicz, 2005). The largest improvements are seen in patients experiencing
extreme symptoms, characterized by Modified Ashworth Scale (MAS) scores of 3+
(Hurvitz, Conti, & Brown, 2003; Jahangir et al., 2007). With this release of spastic
restraint comes improvement in motor control and likely recruitment of high-order motor
centers. By resuming use of the otherwise neglected muscle groups, sensorimotor and
integration areas might increase activity. Specifically, areas such as the premotor cortex,
supplementary motor area, sensory integration regions, and other secondary motor areas
are likely recruited following BoNT injection to compensate for losses in primary motor
output (Maier, 2002). Although it is unlikely higher order areas completely substitute for
the damaged corticospinal tract, adoption of primary motor roles by secondary
sensorimotor areas would suggest neuroplastic effects take place in response to
improvements in focal spasticity.
In order to discern changes in cortical activity resulting from BoNT injection to
the upper-extremity, we utilized a voxel-based analysis of fMRI data obtained from
assisted flexion and extension of the fingers in participants with mild to severe
impairments of the hand. fMRI measurements were made before injection (W0) and at 6
weeks after injection (W6) in participants with stroke and in age-matched controls at a 6week interval. Our approach of correlating the HRF with each individual voxel
separately was used to capture changes in activity throughout the brain, including regions
outside the primary sensorimotor cortices. We hypothesized that BoNT’s peripheral
effects on the affected limb would allow for improved hand function, causing increases in
brain activity in higher order motor control centers.
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2.2 METHODS
2.2.1 Participant Population
This study consisted of fMRI measurements of brain activation in participants
with chronic stroke undergoing BoNT therapy. All procedures were approved by the
Institutional Review Board (IRB) of the Medical College of Wisconsin (MCW). All
participants in this study were contacted through an IRB-approved database of the Stroke
Rehabilitation Center of Southeast Wisconsin, hosted by the MCW Department of
Physical Medicine and Rehabilitation. All participants gave written informed consent to
take part in this study and all procedures were conducted in accordance with the Helsinki
Declaration of 1975 (as revised in 2000).
Nine people with chronic stroke were enrolled in the study (5 female; aged 58.2
+/- 3.8, range 42-77) with the following inclusion criteria: undergoing botulinum
neurotoxin (BoNT) therapy as a part of clinical care; stroke onset more than 6 months
prior to the study; wrist/finger impairment; no contraindication to MRI. All participants
suffered from distal hemiparesis and spasticity of the upper extremity following stroke
and had previously undergone at least one session of BoNT injections. Wrist and finger
flexor spasticity was assessed per the Modified Ashworth Scale (MAS) prior to BoNT
injection (Bohannon & Smith, 1987). Characteristics of participants in the stroke group
are described in Table 2.1, with further details regarding size and location of the lesions
illustrated in Figure 2.1. An age-matched control group (3 female; aged 56.4 +/-2.2,
range 47-70) was enrolled after being screened for the following criteria: no known
neurological or muscular disease and no MRI contraindications.
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Table 2.1: Participant Demographics and Clinical Characteristics. MCA = middle cerebral artery; LD = Lower Division; UD =
Upper Division; Le = Lenticulostriate; Ip = Intraparenchymal; BG = Basal Ganglia; R = Right; L = Left; Isch = Ischemic; Hem =
Hemorragic; Note: information regarding the number of injections and details of physical therapy for participant number 5 was not
available due to transfer between centers.
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Figure 2.1: Lesion Location Map. This image illustrates lesioned areas of all
participants where lesions common among all participants are shown in bright colors
(yellow/white) and lesions specific to few participants are shown in dark red. Lesion
maps have been overlaid on the Montreal Neurological Institute (MNI) 1mm template
and all right hemisphere lesions have been flipped to the left hemisphere for analysis.
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2.2.2 Treatment
Using EMG guidance, participants were treated with intramuscular injections of
BoNT administered to the affected arm as part of normal clinical treatment. All
participants received several injections at numerous locations of the upper extremity,
ranging in both dosage and dilution (see Appendix C; injection locations, dilutions, and
dosages reference only the treatment for this study; prior injections may have had
different locations and/or doses). The prescribed amount varied based on each patient’s
functional abilities, comfort levels, and physical characteristics. Effects of BoNT
treatment were assessed using fMRI measures of brain activity and the upper extremity
motor portion of the Fugl-Meyer Assessment (FMA).

2.2.3 Data Collection
This study consisted of two test sessions scheduled six weeks apart. For
participants receiving BoNT therapy, each session included an MRI scan and a clinical
assessment. At least 3-4 months had passed since the patients’ most recent BoNT
injections before being enrolled in this study. The first session was conducted 1-4 days
before participants received their BoNT injection (W0), and the protocol was repeated six
weeks post-injection in the second session (W6). The control group participated only in
the imaging portion of the procedures, with the exception of participants C1 and C5, who
did not attend the second session.
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IMAGING DATA ACQUISITION

All images were collected using a 3.0T GE Discover MR750 scanner equipped
with a 32-channel head receive coil (MR Instruments, Inc.; Distributed by GE
Healthcare; frequency: 127.73 MHz; field: 3T). Anatomical 3D images were collected
using the following fast spoiled gradient echo planar imaging (FSPRG-EPI) protocol: TE
= 3.2 ms, TR = 8.16 ms, FOV = 240 mm, and 156x1 mm slices. Two 6-minute trials
were conducted for the fMRI, using a GE’s gradient echo planar imaging (GRE-EPI)
protocol following the listed parameters: TE = 25 ms, TR = 2000 ms, FOV = 224 mm,
Matrix: 64x64 mm, and 41x3.5 mm sagittal slices.

TASK

Due to spasticity, some participants with stroke were unable to fully extend the
fingers without assistance. To counteract this issue, a device was created to aid in finger
extension and was used by all participants during the task-based fMRI assessment. The
device is described and depicted in Figure 2.2. All participants were able to actively flex
against the resistive bands while the device acted to passively extend the fingers.
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Figure 2.2: Sketch of Assistive Finger Extension Device. This device was created to
assist finger extension of stroke participants experiencing severe spasticity. Velcro straps
attached to the patient’s first four digits and connected to an elastic band (Theraband:
10.7 N resistance at 100% elongation, 15.1 N at 200%). The bands facilitated extension,
stretching the fingers up and away from the palm of the hand, and were supported by an
outrigger that spans out over the top of the hand. During the task performed in the
scanner, the bands produced approximately 5.1 N to the fingers to aide in extension. A
plastic brace served to stabilize a participant’s forearm and wrist as they are instructed to
flex and extend the digits.

Participants were scanned while prompted by a visual cue to perform full-hand
flexion and extension using the affected (stroke group) or non-dominant (control group)
hand. A visual cue was presented in a block paradigm, which alternated rest and hand
movement at 20-second intervals for a total of 6 minutes (Figure 2.3 & 2.4). Each
participant performed two experimental runs. The two experimental runs underwent
image preprocessing separately. The data were then concatenated and trimmed for
statistical analysis on a single data set representative of a single session. A detailed
description of data processing follows.
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Figure 2.3: Visual Presentation Prompt. The above diagram shows the visual prompt
all participants saw within the scanner. The cue was presented on a screen inside the
bore and read “Relax” centered in a magenta circle (20 s) and “Open/Close” centered on
a cyan circle (20s, 1 Hz); this rest-movement block pair persisted for 9 repetitions.

Figure 2.4: Block Design of Task. The above diagram visually represents one trial of
the motor task, which consisted of 20 seconds of rest followed by 20 seconds of finger
flexion/extension controlled at a rate of 1 Hz. These intervals are denoted above where
white blocks represent rest (R) and grey blocks signify flexion/extension (F/E). A model
of the canonical hemodynamic response function (Model Data, solid line) was fit to data
recorded as a single voxel (Experimental Data, dashed line) over the timecourse of a
single trial.
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CLINICAL ASSESSMENT

Following the MRI portion of the session, all participants with stroke were
assessed using the FMA to quantify impairment of the affected arm. The upper extremity
portion of the FMA was conducted before and six weeks after receiving BoNT injections
(W0 and W6). The FMA is designed to evaluate movement control, reflex activity,
coordination, and muscle strength and was originally designed as a measure of motor
impairment for stroke survivors. The upper extremity FMA motor scale specifically
assesses movements of the hand, wrist, and upper extremity and totals to 66 points, with
each category ranging from 0 (totally impaired) to 2 (no impairment) (Fugl-Meyer et al.,
1975).

2.2.4 Data Analysis
Changes in the volumes of brain activation with BoNT treatment in participants
with stroke were compared to changes in repeated measures of brain activation in agematched controls. Activation maps were computed for each participant, along with group
average activity maps, and between-session contrasts of each test group were compared.
The pipeline for image processing is summarized in Figure 2.5 and a detailed description
follows.

DATA PREPROCESSING

Prior to image analysis for the quantification of brain activity, all data underwent
several preprocessing steps. After collecting data, DICOM files were converted to NIFTI
format using Mricron’s dcm2nii software. The 4D data sets from the two trials were
concatenated and trimmed for final statistical analysis; the first 4 TRs were removed to
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account for magnetic stabilization (Diedrichsen & Shadmehr, 2005). Using the Oxford
Center for Functional MRI of the Brain Software Library (FSL), participant data were
first reoriented to a standard orientation (Jenkinson, Beckmann, Behrens, Woolrich, &
Smith, 2012). Correction for intensity differences on the outer edges of the brain was
performed using the Advanced Normalization Tools (ANTs) software’s
N4BiasFieldCorrection command (Avants et al., 2009). Using FSL’s Brain Extraction
Tool (bet), the skull and other non-brain matter was removed from both T1-weighted and
fMRI images (Jenkinson et al., 2012).
All stroke participants with left-arm hemiparesis (i.e. right hemisphere brain
lesions) and control participants that self-identified as right-hand dominant were flipped
in the right-left direction to allow for group analysis of movement using the nondominant hand. The R-based Lesion Identification with Neighborhood Data Analysis
(LINDA) program—which requires lesions to be located in the left hemisphere—was
used to create lesion masks for all stroke participant T1-weighted images (Pustina et al.,
2016). These masks were manually edited as necessary depending on LINDA’s
accuracy. Masks were overlaid on each participant’s anatomical T1 image to assess the
precision of the lesion detection. Upon visual inspection, LINDA at times under- or
overestimated the size of the lesion. In these cases, the masks were manually expanded
(or reduced) to better reflect the lesions’ actual pathology. Using FSLView’s masking
tool, voxels were manually added and removed from the mask to ensure all lesioned areas
were included in the mask.
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Figure 2.5: Processing Pipeline. The primary steps taken during image analysis in order
to arrive at the final results are summarized. The pipeline begins with participant-specific
data and results in group average results that were used to visualize between-session and
between-group differences.
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REGISTRATION

In general, fMRI data were registered to a Montreal Neurological Institute (MNI)
standard brain and underwent statistical analysis to identify brain activity during
movement of the impaired (non-dominant) hand. For registration, each participant’s T1
weighted anatomical image was aligned to a standard MNI 2mm-voxel brain for
comparison of images in standard space. Both linear and nonlinear registrations of the
T1-weighted image were carried out using the ANTs software. First, linear registration
was performed using a rigid algorithm to perform necessary rotations and translations. A
second-level linear transformation was done using an affine algorithm to perform
shearing and scaling of the image to match the MNI template. Lastly, nonlinear
registration was performed using a symmetric-normalization (SyN) algorithm (Avants et
al., 2008). This top-performing algorithm is a diffeomorphic registration, which allows
for flexible local matching of tissues in the brain to the template (Klein et al., 2009). It is
considered symmetric because its outputs allow for transformation from subject-space to
standard-space as well as the inverse transformation from standard-space back to subjectspace. This process produced 3D warp (nonlinear) and an affine (linear) transformations
that were then applied to the 4D functional data over all volumes, resulting in the
normalized datasets that were subsequently used to determine neuronal activity in the
brain.

DETERMINING NEURONAL ACTIVITY

Neuronal activity was assessed by utilizing statistical maps in which statistical
parameters (z-score) were indicative of correlation with the hemodynamic response
function on a voxel wise basis. FMRI analyses were carried out using the fMRI Expert
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Analysis Tool (FEAT) Version 5.0, a subsection of FSL. First-level FEAT analysis was
performed on individual data using a Fixed Effect (FE) analysis. Data were corrected for
motion using FMRIB’s Linear Image Registration Tool (MCFLIRT). Spatial smoothing
was performed on data using a full-width/half-maximum (FWHM) Gaussian kernel of 5
mm. The data were filtered temporally with a 0.01 Hz high pass filter to remove
unwanted low-frequency signals (i.e. breathing, heartbeat, drifts within the scanner).
Data were also prewhitened using FMRIB’s Improved Linear Model (FILM), which uses
nonparametric estimations of the time series autocorrelation to prewhiten each voxel’s
time series to improve estimation efficiency.
A model of the expected hemodynamic response (HDR) was created using
FEAT’s General Linear Model setup to convolve the binary block design with a Gamma
wave (phase = 0s, std. dev. = 3s, mean lag = 6s). Statistical analysis of each voxel’s
timeseries was performed using the FMRIB’s Improved Linear Modeling (FILM) to
correlate the time series to the model. The activation images (Z-value, Gaussianized T/F
statistic (Jenkinson & Woolrich, 2000) went through a cluster-threshold using Z > 2.3,
resulting in a corrected cluster significance of p < 0.05. This first-level analysis created
each participant’s activity map at each session, where higher z-scores indicated a greater
probability of a given voxel being associated with the motor task. These maps were later
used to quantify volume of activation and areas that correlated highly with the task.

GROUP MEAN ACTIVITY & CONTRASTS

Group analysis was performed using FMRIB’s Local Analysis of Mixed Effects,
Stage 1 (FLAME1). A general linear model (GLM) was used to categorize individual
participants by participant type (Stroke/Control) and session (W0/W6). The GLM is a
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binary matrix meant to assign each data set to one of four groups, with participants as a
random factor: control at W0, control at W6, stroke at W0, and stroke at W6. Group
mean activation maps were created using nonparametric permutation testing for each
group at a threshold Z > 2.3 and cluster significance p < 0.05. FSL’s False Discovery
Rate (FDR) was used to correct for multiple comparisons.
Contrasts between the two sessions were calculated for both control and stroke
groups, using a two-sample paired t-test. Control and stroke groups were analyzed
separately to account for difference in population variance. Significant differences (Z >
2.3, p < 0.05) found between sessions in stroke participants can thus be attributed to
effects resulting from the BoNT injection over time. Contrasts between time points for
controls were used as a method of verification and to test for the existence of an
interaction effect from the BoNT therapy.

ACTIVE VOLUME AND AVERAGE CORRELATIONS OF REGIONS OF INTEREST

Regions of interest (ROIs) assessed in this study were identified by contrast
analysis between W0 and W6 sessions of the stroke group. Clusters showing a
significant difference in signal following BoNT injections were broken into individual
ROIs based on anatomical structure and function using the Jülich Histological Atlas for
regions in cortical and subcortical areas; because cerebellar areas are not included in the
Jülich Atlas, the Taliarch Daemon Label Atlas was used to identify regions within the
cerebellum. Clusters containing more than one anatomical area were overlaid with the
atlas’s predefined probability maps of the regions of interest, creating masks where the
anatomical area and cluster overlapped.
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Binary masks of each cluster-based ROI were created and used as an input to
FSL’s featquery tool. Featquery was used to count the number of active voxels within
each ROI within that region for each participant-specific dataset. In addition to active
volume, the average z-score (correlation to the HRF) was calculated using all voxels
contained within the ROI resulting in a representative z-score for the region. These data
were used as quantitative measures to assess the impact of BoNT on activation patterns
related to movement.

CORRECTION FOR LESIONED BRAIN MATTER

Due to the large number of cortical lesions in the participant pool, group means
and contrasts were recalculated while correcting for lesion location. The goal of this
approach was to determine if any changes in activation were seen in the common
lesioned areas, primarily in the lesioned M1. Participants that were identified as having a
lesion in a specific location were excluded from statistical analysis. Using this technique,
statistical analyses were performed using information coming only from viable brain
tissues that were capable of activation. This also resulted in each voxel having different
statistical power because of variations in the number of samples included in each
calculation.
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2.3 RESULTS
Activity patterns were analyzed from all participants in this study both
individually and in groups according to participant type (stroke/control) and session
(W0/W6). Main effects were seen comparing stroke and control groups, but no effect
was seen comparing sessions alone. No significant difference was observed comparing
sessions in the control group. The stroke group, however, showed significant increases in
activity from W0 to W6, indicating an interaction effect had taken place in stroke
survivors in response to the BoNT intervention.

2.3.1 Imaging: Subject-Specific
Individual participants’ activity maps for those in the control group showed
consistent patterns of activation in bilateral primary motor (M1) and ipsilateral
cerebellum areas at W0 and W6. The activity map associated with non-dominant hand
movement in a representative healthy control is shown at W0 and W6 in Figure 2.6.
Though this pattern was common among all control participants, activity patterns for
participants in the stroke group showed more variability in individual maps. Unlike the
control participants, which largely showed similar activity patterns at each session, stroke
participants showed differences in activation between W0 and W6. An example of the
activity pattern of a representative participant with stroke is illustrated in Figure 2.7. This
participant showed widespread brain activation in several areas outside the primary motor
cortex that increased from W0 (Figure 2.7a) to W6 (Figure 2.7b). Most stroke
participants showed an increase in whole brain active volume with several areas showing
increased activity following BoNT injections. This trend excludes participant BTX7,
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who showed an overall decrease in whole-brain active volume; it is worthwhile to note
this participant’s low spasticity rating and high functional ability, a distinctive trait as
compared to the other stroke participants.
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Figure 2.6: Single Control Participant Activation Pattern. The mean BOLD activity
associated with task performance is shown for participant C7 at W0 (a) and W6 (b). No
apparent changes were seen in the control participant data over time.
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Figure 2.7: Single Stroke Participant Activation Pattern. The mean BOLD activity
associated with task performance is shown for participant BTX5 at W0 (a) and W6 (b).
Signal increased in both volume and average z-score following the BoNT injection
therapy.

2.3.2 Imaging: Group Averages
The average activation map for the control group was calculated using all
participant data from both W0 and W6 after taking account for repeated measures. This
group average of BOLD activity during hand movement for all control participants is
shown in Figure 2.8. The contralateral primary motor cortex (M1) and ipsilateral
cerebellum appear to be the areas exhibiting the highest volumes of activity. In addition
to these primary motor areas, the following areas also showed significant activity:
ipsilateral premotor cortex, ipsilateral supplementary motor area, hand portion of the M1,
and various areas of the basal ganglia.
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Because the individual data maps showed clear differences between W0 and W6
for stroke participants, group average maps were calculated separately for each time point
(Figure 2.9). At W0, group results showed minimal activation, including areas limited to
the cerebellum, occipital cortex, and small portions of the hand region of M1 (Figure
2.9a). Conversely, at W6 group maps showed widespread activity throughout the whole
brain. Areas of activation included the cerebellum and occipital cortex (as seen at W0) as
well as areas in the ipsilateral and contralateral primary motor cortex, hand area of M1,
and the basal ganglia (Figure 2.9b). Group activity maps for the stroke participants
following the lesion-correction analysis showed similar patterns, and are documented in
Appendix E. While the W6 group average showed notable increases in primary and
secondary motor regions, it is clear that areas outside of the primary motor cortex become
engaged as well.
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Figure 2.8: Group Activity Maps of Control Participants. The above panel shows
slices of the MNI template overlaid with z-statistic (Z > 2.3) maps of the averaged control
group activity during non-dominant hand movement. Activity maps indicate volumes in
which there was significant (p < 0.05) levels of activity across the group. The right
hemisphere of the brain is displayed on the left.
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a.

b.

Figure 2.9: Group Activity Maps of Stroke Participants. Each panel shows axial slices
of the MNI template overlaid with z-statistic maps of the averaged stroke group (a)
before BoNT injection and (b) six weeks after injection. Activity maps indicate volumes
in which there was significant (p < 0.05) levels of activity across the group. The right side
of the brain is displayed on the left.
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2.3.3 Imaging: Contrasts
Whole brain comparison of BOLD signal in the stroke group at W0 and W6
revealed significant differences in cortical activation following BoNT intervention. A
significant increase in BOLD activity was seen in several regions including premotor,
cerebellar, and sensory integration areas following BoNT injections (P < 0.05; paired ttest) (Figure 2.10a). These increases in activation appeared in clusters that spread across
several anatomical and functional areas (Figure 2.10b). The voxel-based approach
revealed three significant, connected clusters of voxels, from which five anatomical and
functional regions of interest were identified: 1) ipsilateral premotor cortex (PMC-R), 2)
ipsilateral cingulate gyrus (CG-R), 3) ipsilateral thalamus (Th-R), 4) superior cerebellum
(S-CB), and 5) somatosensory and visual integration areas (Sens-IA). These regions are
further are described in Table 2.2 and illustrated in Figure 2.11.
Following lesion correction, no significant difference was seen in the contralateral
M1, which was originally hypothesized. Small areas of increased activation were
identified throughout the contralateral hemisphere that did not reach a significant value.
These increases in activity following lesion correction are illustrated in Appendix E.
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Figure 2.10: Contrast between Stroke Participants Before and After BoNT
Intervention. Significantly activated voxels (Z > 2.3, p < 0.05) are overlaid on a standard
MNI brain (a) illustrating areas that showed a significant increase in activity following
the BoNT intervention. These active areas were observed in three clusters (b) indicated
by red, blue, and green volumes.
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Table 2.2: ROI Characteristics
Main Region of Interest

Abbreviation

Size (Voxels)

Region Description

Premotor Cortex

PMC-R

441

64% GM Premotor Cortex BA6 R
14% GM Primary Motor Cortex BA4a R

Cingulate Gyrus

CG

758

40% WM Cingulum R
18% WM Callosal Body

Right Thalamus

Th-R

855

78% Right Thalamus
19% Right Cerebral, WM

Superior Cerebellum

S-CB

298

Right Cerebellum
Anterior Lobe
Cerebellar Lingual

2680

55% Inferior Temporal Gyrus, temporo-occipital part;
14% Temporal Occipital Fusiform Cortex
7% Lateral Occipital Cortex, inferior division
3% Occipital Fusiform Gyrus

Sensory Integration Area

Sens-IA

Note: Probabilities describing each ROI’s anatomical makeup were determined using Jülich Histological Atlas
for cortical ROIs and the Taliarch Daemon Label Atlas for at the voxel of greatest z-score overlaid onto a 2 mmMNI brain.
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Figure 2.11: Defining Regions of Interest. Using the clusters identified in Figure 2.5,
regions of interest were identified and further segmented into regions of interest utilizing
the Jülich Histological Atlas for cortical regions and the Taliarch Daemon Label Atlas for
cerebellar regions. (a) PMC-R (b) CG-R (c) Th-R (d) S-CB (e) Sens-IA.
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2.3.4 Activation Volume and Correlation Analysis
The five data-defined ROIs were used as masks to identify the number of active
voxels and average z-score in the given volume for the stroke group at W0 and W6
(Figure 2.12 & 2.13). Participants with stroke showed increased activity in the PMC-R
region by 40.5%, CG-R by 38.7%, Th-R by 37.3%, S-CB by 46.7%, and Sens-IA by
39.2% of total ROI volume (p < 0.05). The average z-score within each ROI also
increased following BoNT injections; analysis showed significant increases in z-scores of
0.87 to 3.43 in the PMC-R, 0.70 to 2.77 in the CG-R, 0.80 to 3.14 in the Th-R, 0.91 to
3.28 in the S-CB, and 1.17 to 3.78 in the Sens-IA respectively (p < 0.05).
The stroke group showed higher volume of activation in all mentioned ROIs at
W6 than controls at either time point (p < 0.05). Controls showed greater volume of
activation in the contralateral M1compared to stroke participants at W0 (p < 0.05), but
showed no significant difference at W6. No significant difference was found between
sessions for control participants. There were no areas that showed significantly
decreased activity following BoNT injections.
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Figure 2.12: Changes in Activation Volume Following BoNT Injection Therapy. All
areas of interest show a significant difference in active volume between sessions. Control
group results showed no difference between sessions, and are not included in this figure.
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Figure 2.13: Changes in Average Z-Score Following BoNT Injection Therapy. All
areas of interest show a significant difference in average intensity between sessions.
Control group results showed no difference between sessions.

2.3.5 Clinical Assessment
Participants showed a significant increase in FM motor scores following
injections of BoNT to the affected arm (p < 0.01; paired t-test). Nearly all participants
receiving BoNT showed an increase in FM-UE scores following injection therapy (Table
2.3), showing a mean increase of 1.8 +/- 0.2 points increase. Four of nine participants
showed improvement of wrist function, and three showed improvements in finger
extension. Those that improved in finger extension had the highest MAS scores prior to
injection.
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Correlations were performed between activation volume, activation intensity, and
clinical measurements (MAS, FMA). General trends between the initial MAS scores and
activation volume at W6 were identified, although they did not reach a level of statistical
significance. These included minor correlations between initial MAS scores and the
changes in Sens-IA ROI volume (r = 0.53, p < 0.142) and average z-score (r = 0.54, p <
0.135). Additionally, initial MAS scores were correlated with active volume in the
ipsilateral hemisphere (r = 0.51, p < 0.166). Patient BTX7 showed substantially higher
functional ability in the affected limb as compared to other stroke participants, indicated
by physical characteristics, initial MAS score, and FMA scores at both W0 and W6. It is
important to note that this participant alone showed decreases in cortical activity
following BoNT intervention.

Table 2.3: Fugl-Meyer Scores
Patient No.

FM (W0)

FM (W6)

BTX 1

23

26

BTX 2

26

27

BTX 3

19

22

BTX 4

20

22

BTX 5

9

9

BTX 6

23

25

BTX 7

63

63

BTX 8

44

47

BTX 9

35

40
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2.4 DISCUSSION
In this study, we found evidence of the effects of BoNT on higher-order brain
activation using fMRI. Following BoNT intervention, an interaction effect was seen in
significant increases in the BOLD signal in the contralesional premotor cortex (PMC-R),
cingulate gyrus (CG-R), and motor thalamus (Th-R), ipsilesional sensory integration
regions (Sens-IA), and bilateral superior cerebellum (S-CB). These regions of interest
showed increased activity, characterized by both larger volume of activation and greater
correlation to the HDR. The results suggest that in people with severe spasticity, BoNT
can enable activation of higher motor centers, possibly associated with renewed access to
motor planning and control of movement.

2.4.1 Activation Patterns in Control and Stroke Groups
CONTROL

Traditionally, cortical motor function is reliant on the supplementary motor area
to plan movements and the primary motor cortex to execute said plan (Ghez, Hening, &
Gordon, 1991). Additionally, somatosensory areas interpret sensory information to
assess the performance as compared to the plan, and adapt accordingly (Fetz, Finocchio,
Baker, & Soso, 1980; Flament & Hore, 1988). These findings have been verified using
fMRI, indicated by BOLD-induced signals produced during movement (Meier, Aflalo,
Kastner, & Graziano, 2008; Olman, Pickett, Schallmo, & Kimberley, 2012).
In the present study, analysis of control subjects showed significant activation of
the contralateral primary motor (M1), supplementary motor (SMA), cingulate motor
(CMA), premotor, and somatosensory areas (S1), as well as the ipsilateral cerebellum.
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Ipsilateral premotor and primary S1 were also activated, though to a lesser degree than
the equivalent contralateral regions.
Our results of activation patterns for the control group were consistent with
previous studies, which vary in task protocol (Meier et al., 2008; Olman et al., 2012).
Reproducible activation patterns are observed in the contralateral primary,
supplementary, and premotor areas as well as the ipsilateral cerebellum during repetitive
hand movements (i.e. finger tapping, finger sequence patterns, whole-hand
flexion/extension) (Yoo et al., 2005). Additionally, EEG/fMRI shows higher order motor
areas (SMA and CMA) are activated slightly before primary motor areas, and are
believed to trigger actual motor movement by releasing inhibition of the primary motor
cortex (Ball et al., 1999). Engagement of the primary somatosensory cortex (along with
previously established motor areas) has also been shown during executed movement, an
area of activation not seen in imagined movement (Lotze et al., 1999). Similar activation
patterns have been seen among passive and active movements of the hand, with passive
movements engaging the same regions but less volume, which is thought to be due to the
removal of motor drive (Boldyreva et al., 2014).
The motion of making a fist combines the simple task of single finger flexion and
has been shown to produce nearly identical activation patterns. Comparing movements
of the same joint which involve different muscles (i.e. flexion/extension v.
abduction/adduction of a single finger) shows a large overlap of the hand/fingers sites on
the primary motor and somatosensory cortices (Lotze et al., 2000). Although voluntary
movement of the hand is classically thought to be controlled by the contralateral cortex,
ipsilateral motor areas might also be involved. Engagement of the ipsilateral M1 during
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unilateral hand tasks remains controversial, as bilateral activation is inconsistently
observed in fMRI studies. Previous findings suggest a positive correlation between the
volume of activation in ipsilateral motor areas and the precision required for the task,
complexity of the task, and duration of the movement (Buetefisch et al., 2014; Verstynen,
2004; Newton, Sunderland, & Gowland, 2005; Bernard et al., 2002).

STROKE

Severity of motor impairment has an impact on functional activity patterns related
to hand movement in stroke survivors. Stroke survivors with recovered motor function
show activity patterns similar to those produced by healthy controls, often exhibiting less
localization and more active volume (Cramer et al., 1997; Nair et al., 2007). Movement
of the unimpaired hand elicits nearly identical patterns to those seen in controls; however,
in stroke survivors with motor impairments, movement of the affected hand activates
areas of the motor cortex that are spatially distinct from those produced during movement
of the unaffected hand (Cramer et al., 1999). Study participants exhibiting severe deficits
often recruit motor areas outside the primary motor cortices including supplementary
motor areas, cingulate motor areas, premotor cortices, and cerebellar regions (Ward et al.,
2003). Poor motor outcome in chronic stroke is associated with changes in
interhemispheric balance, shifting cortical activation to the non-lesioned hemisphere to
provide compensation for areas damaged by the infarct (Cramer & Crafton, 2006). These
foundational findings have fueled fMRI research to determine neural correlates of motor
recovery following stroke and to design therapies to facilitate these neuroplastic changes
(Buetefisch, 2015; Johansen-Berg et al., 2002; Jones et al., 2015; Michielsen et al., 2011;
Rehme, Fink, Von Cramon, & Grefkes, 2011; Schaechter et al., 2002).
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COMPARISON BETWEEN CONTROL AND STROKE

The tasks chosen for movement-based fMRI analysis in both control and stroke
related studies show a wide variety of complexity and involvement, all of which produce
near-identical activation patterns. Comparing activation maps between the present and
past studies, both control and stroke groups show more extensive contralateral
somatosensory activation compared to prior studies (Schaechter et al., 2008; Cramer et
al., 1997). It is possible that this larger area of activation is due to the increased sensory
stimulus elicited by the assistive device. Congruency between current and previous
findings in control participants regarding the involvement of all contralateral motor areas,
as well as ipsilateral cerebellar areas provides further validation of our imaging methods.
Activation in control participants’ ipsilateral motor areas could be explained by
the long blocks of movement and the target of achieving a fully formed fist and extended
hand (Newton et al., 2005). Similar results are to be expected when comparing motor
tasks ranging from single-joint finger tapping to mass flexion and extension of the hand
due to the similarity of the movement tasks (Lotze et al., 2000); contrasts seen between
control and stroke groups might be due to the difficulty of the present study’s task
(Verstynen, 2004). In controls, minor recruitment of ipsilateral secondary motor areas
may be a result of the uniqueness of a task comprised of assisted extension and resisted
flexion, even if the movement is not considered challenging. Furthermore, higher order
motor areas recruited by stroke subjects with large impairments may be due to the
additional effort and planning required to perform a seemingly simple motor task
(Bernard et al., 2002).
Our findings in differences in control and stroke participant activation patterns
associated with hand movement are consistent with previous results. Stroke participants
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tend to have much more variety in cerebral activation patterns, particularly when
compared to neurologically intact control subjects (Ward et al., 2003; Cramer et al., 1997,
1999). Comparing activation of the contralateral M1 between groups, controls showed
significantly higher volume and magnitude of activation in the primary motor cortex (p <
0.025) than BoNT participants, even following the therapy. This is likely due to the
control group’s ability to perform the task fully, as movement amplitude and M1
activation in fMRI have been positively correlated (Waldvogel, van Gelderen, Ishii, &
Hallett, 1999). Although this increase was not significant following contrast analysis, it
is possible that this trend might become more apparent with a larger sample size.

2.4.2 Motor Areas of Activation Unique to Stroke
Activation patterns related to hand motor tasks in stroke participants have been
examined with regards to motor recovery and therapy outcomes. Reports vary greatly in
study design but show consistently more disperse activity patterns in stroke populations
as compared to neurologically intact populations (Cramer et al., 1997, 1999; Schaechter
et al., 2002; Ward et al., 2003;). Studies on early post-stroke motor recovery have
demonstrated correlations between the contralesional primary motor cortex (M1) and
behavioral recovery, associating high levels of contralesional activation with poor
recovery and inability to fully perform the task (Rehme et al., 2011; Calautti et al., 2007;
Buetefisch et al., 2015; Marshall et al., 2009; Johansen-Berg et al., 2002). Given the
highly impaired participants in the current study, high levels of contralesional
involvement—as seen in both pre- and post-BoNT fMRI data—would be expected. The
present study demonstrates a general trend indicating initial MAS scores may be
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correlated with ipsilateral hemisphere activity; this implies that patients experiencing
severe spasticity require more extensive engagement of ipsilateral structures for
compensation. The overall consensus on the effects of therapy as indicated by fMRI
activity follows a trend of lateralization and localization to the contralateral hemisphere,
generally indicating decreases in overall brain activity. This finding has been reported in
constraint-induced (Johansen-Berg et al., 2002), mirror (Michielsen et al., 2011), and
physical rehabilitative therapies (Cauraugh & Summers, 2005; Schaechter et al., 2002).
Reports on increased activity of higher-order motor areas following therapeutic
interventions, however, remain minimal.
The first group to assess BOLD signal neural correlates associated with the
impact of BoNT injection therapy did not assign a rigorous physical therapy protocol
along with the study (Manganotti et al., 2010). Eight chronic stroke survivors performed
sequential finger tapping during an fMRI; following BoNT injections, activation
decreases in both ipsilateral and contralateral motor areas, showing a clear lateralization
to the affected hemisphere. As it is traditionally recommended, most studies assess the
effects of BoNT in combination with physiotherapy. Diserens et al. (2010) found
increases in activity in contralesional secondary motor areas and the ipsilesional
somatosensory cortex following repetitive arm cycling over a 3 month period. Following
this initial study, more fMRI findings have been discovered by combining BoNT
injections with daily (~1 hr.) rehabilitation training tailored to each participant, with
highly variable results (Senkárová et al., 2010; Veverka et al., 2012, 2014, 2016). Their
initial 4-subject study showed decreases in the posterior cingulate and precuneus regions
(Senkárová et al., 2010). A subsequent study included 14 study participants and extensive
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activity increases are seen within the contralesional thalamus and bilateral cerebellum
while decreases are seen bilaterally in primary, supplementary, and premotor cortices
following BoNT (Veverka et al., 2012, 2014, 2016). Bergfeldt et al. (2015) also
conducted a 6-person study, and documented bilateral decreases in M1, making note that
ipsilateral M1 activity is more greatly reduced. These studies all identify changes in
activity of several primary motor areas following BoNT intervention; however, the
inconsistency in findings surrounding involvement of areas outside the primary motor
cortex suggests further investigation is needed.
In the current study, group results showed increases in contralateral primary
motor cortex and bilateral cerebellar activity following BoNT injections (Figure 2.9b),
congruent with several findings from previous studies involving cerebral changes due to
BoNT and combined therapies (Tomášová et al., 2013). Stroke survivors tend to have
greater variety in activation patterns, often including several areas outside the primary
motor cortex in both the affected and unaffected hemisphere. Cross-session analysis
revealed three clusters in which BOLD activity significantly increased after BoNT
treatment; these three clusters were broken into five main regions of interest: the
contralesional premotor cortex (PMC-R), cingulate gyrus (CG-R), contralesional
thalamus (Th-R), bilateral superior cerebellum (S-CB), and ipsilesional sensoryintegration areas (Sens-IA). Each of these ROIs has been proven to play a supporting
role in motor planning and execution.
Increases in cortical activity after BoNT may be explained by a number of factors.
First, due to the severity of contractures and muscle weakness in most participants, it is
possible the task was unable to be performed even with the assistance of the finger-
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extension device. The release of spasticity by BoNT injections may have allowed for
greater magnitude of the hand movement within the scanner, which could translate to
increases in activity in motor areas. This increase in activity could also be a result of
neuroplastic events occurring as individuals incorporate the affected arm into daily use,
as BoNT works to gradually release spasticity over six weeks. Additionally, previous
studies identified similar activation patterns among passive and active movements, where
passive movement produced a weaker response due to the removal of motor control
(Bernard et al., 2002); this finding is congruent with the hypothesis that BoNT injections
allow for increased motor control and explains why these areas of activation would
increase in volume.
Increased activity in higher-level motor areas could also be a result of repeated
injections. Documentation of the cortical activation changes associated with BoNT have
primarily focused on first-time injections; because long-term BoNT injection therapy
itself tends to exhibit a plateau-effect, it is likely that activity patterns change
accordingly. The present study assesses these changes following repeat injections,
wherein no present literature is available for comparison.
Additionally, prior studies have included intense rehabilitative therapy regimens
for all participants receiving BoNT injections (Diserens et al., 2010; Veverka et al., 2012,
2014, 2016; Bergfeldt et al., 2015). Similar activation patterns are shown in studies
assessing cortical activation changes following motor recovery due to physical therapy
methods regardless of the presence of BoNT injections; it is likely that these training and
therapy methods are largely responsible for the general trend of localization and
lateralization to the contralateral M1 seen in prior studies (Schaechter et al., 2002;
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Johansen-Berg et al., 2002; Ward et al., 2003). Physical therapy regimens were not
controlled in the present study, which may explain why this pattern was not seen in the
fMRI results.
Too often in fMRI studies, regions of interest are often predetermined based on
predicted outcome, identifying premotor and primary motor cortices as major targets.
This tendency can often cause less-obvious patterns to be overlooked when observing
group-average activity maps; to address this issue, significance testing on the contrast
between sessions can filter out areas of non-significant changes in activity. The present
study’s data analysis was performed using a voxel-based approach to identify
involvement of higher order motor areas that might be engaged following BoNT
intervention. By analyzing each voxel independently, clusters directly associated with
the task can be identified across the whole brain. The use of a contrast approach allows
for detection of significant differences in activity between sessions, presumably the
broader motor areas involved in motor planning and execution that are thought to adapt to
compensate for lost primary control.
The individual data-defined regions of interest have all been related to roles
involved in motor control by functional and structural connections shared between the
ipsilateral premotor cortex (Calautti et al., 2007; Johansen-Berg et al., 2002), cingulate
gyrus (Dum & Strick, 1991; MacDonald et al., 2000; Barbas, Henion, & Dermon, 1991;
Montaron & Buser, 1988), motor thalamus (Bosch-Bouju et al., 2013; Vitek et al., 1994;
Middleton & Strick, 2000; Mushiake & Strick, 1993), superior cerebellum (Mottolese,
Szathmari, Beuriat, Sirigu, & Desmurget, 2015; Timmann et al., 2008), and sensory
integration areas. It is possible that the regions together act as a new internal model for
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hand movement, developed post-stroke due to disuse of the affected arm. Furthermore,
higher order motor control structures are required to compensate for the loss of primary
motor cortical drive.

2.4.3 Effects of BoNT Therapy
BoNT therapy is a safe and effective method for managing symptoms of spasticity
and has become a frontline treatment for focal or multifocal spasticity (Elovic et al.,
2008; Hesse, Reiter, Konrad, & Jahnke, 1998; McCrory et al., 2009; Shaw et al., 2011;
Sheean, 2006). Best outcomes are seen in patients when action is taken during early
stages of symptoms, preventing soft tissue shortening from limb immobility (Kaji et al.,
2010; Smith, Ellis, White, & Moore, 2000). Injections of BoNT are effective in
improving rehabilitation outcomes, resulting in better mobility as compared to groups
receiving a placebo (Gracies et al., 1997; Marciniak et al., 2012; Rosales et al., 2012).
Use of BoNT injections to treat spasticity in participants of the current study
helped reduce spasticity and slightly decrease motor impairment, as indicated by a
significant increase in FM motor scores (p < 0.01). The components in which scores
improved were often related to improved wrist strength, as seen in 4 out of 9 patients.
Other areas of improvement (mass finger extension, forearm pronation/supination,
shoulder flexion and abduction) varied between participants, most likely impacted by
injection location and dose.
Prior BoNT injections in participants of the current study might have influenced
the results. Prior studies assessing the effects of BoNT injections use participants naïve
to the therapy, documenting greater improvement following first-time injection (Hesse et
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al., 1998, 2001; Hurvitz et al., 2003). It is possible that the small increase in FM score
after the injections in the current study, though significant, could be limited by
improvements that already occurred following prior injections. Patients appear to
experience a greater change in clinical scores following their first injection, while followup injections serve primarily to maintain the spasticity reduction. This model would show
a plateau effect in clinical scores when documenting long-term use.
Some have concluded that BoNT injections provide best results when
administered shortly after symptoms occur (Kaji et al., 2010; Smith et al., 2000). The
minor improvements seen in this study’s FM scores could be a result of the timeframe in
which patients received their first injection following the appearance of spastic
symptoms. If the study group dealt with symptoms for substantial time period before
seeking treatment, it would follow that their improvements following BoNT would be
less pronounced. Because the onset of these symptoms is not specifically recorded, this
hypothesis cannot be tested.
The efficacy of BoNT to improve peripheral motor impairment was seen in
changes in cortical activation following treatment. It is possible that the increased
activation seen in contralateral primary motor areas was elicited from greater magnitude
of movement within the scanner; however, this increase in activity was not significant
following the subject-paired contrast analysis across timepoints (W0 v. W6). While
ability to perform the task may have improved slightly following BoNT injections, it does
not compare to that of the controls, which showed significantly greater activation.

57
2.4.4 Study Limitations
The study enrolled a small sample, and it is possible that including more
participants would provide more areas of significant difference. Despite the low number
of participants, results showed consistent patterns among each group. One limitation to
the present study is the lack of measurement of hand movement while in the scanner.
Quantification of increased movement or lack thereof would have proven helpful in
drawing final conclusions on the effects of BoNT injections. A real-time measurement of
hand movement would have the potential to control for mirror movements that are often
seen in stroke survivors trying to perform tasks with a significantly impaired limb (Ejaz
et al., 2018; Nelles, Cramer, Schaechter, Kaplan, & Finklestein, 1998; Ohtsuka,
Matsuzawa, Ishii, & Shimizu, 2015). It is possible that activity seen in ipsilateral motor
areas may have resulted from mirror movements of the unaffected hand, though it is
unlikely because mirror movements would have been present both before and after BoNT
injection.
Assessments of improvements in spasticity was limited by the documentation of
the MAS only prior to the injection; a follow-up measure to quantify improvements in
spasticity would add to the interpretation of the BoNT effects. Likewise, the FMA is a
measure of motor impairment rather than functional ability. Additional tests such as the
Wolf Motor Function Test (WMFT) and the Box and Blocks test would have added
beneficial information regarding any changes in functional ability following BoNT
injections (Mathiowetz, Volland, Kashman, & Weber, 1985; Wolf et al., 2001). All
participants performed physical therapy exercises tailored to their specific needs.
Physical therapy treatment plans, duration, and frequency were not controlled, but

58
assumed to remain constant over the six-week period of involvement in the study.
Neither injection site nor dose were controlled for, as each participant showed varying
levels of spasticity. The total number of injections received ranged from 2 to 50+
injections over the participants’ lifetimes but did not show any correlation with effect of
the injection.

2.5 CONCLUSION
This study showed differences between control and stroke brain activation
patterns in response to an assisted hand flexion/extension task that were generally
consistent with previous reports. The results also showed an interaction effect due to
BoNT treatment, demonstrating increased cortical activation in higher-order motor areas
following BoNT injection therapy in highly impaired stroke participants performing
hand-motor tasks. It is likely that these areas of increased activation play a compensatory
role in highly impaired participants and allowed for the production of movements
regained through the release of spasticity.
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CHAPTER 3: CONCLUSIONS AND FUTURE DIRECTIONS

3.1 LONGITUDINAL EFFECTS OF BOTULINUM TOXIN INJECTIONS: CLINICAL,
FUNCTIONAL, AND FMRI OUTCOMES
A current limitation to the present study was the inability to assess long-term
longitudinal effects of BoNT injections on relieving spasticity. Injections show the
greatest improvements in patients who seek treatment shortly after the onset of symptoms
(Burbaud et al., 1996; Mohammadi, Abdoulrahmani Balouch, Dengler, & Kollewe,
2010). Evidence has shown BoNT therapy to exhibit the greatest effects following firsttime injection, where repeated injections act to maintain the initial improvement (Gordon
et al., 2004). It would follow that these follow-up injections, which are intended to
maintain symptoms, would elicit different activity patterns at different timepoints, as
indicated by fMRI. The present study observed these patterns, showing results that
understandably varied from past studies that looked into first-time injections only.

3.1.1 Long-term Effects of BoNT Injections on Functional Ability
While long-term use of BoNT injections as a method of treatment for post-stroke
spasticity has been concluded to be safe and effective, the impact on functional outcome
remains unclear. Longitudinal studies have evaluated kinematic improvements in
spasticity following treatment, quantified by changes in MAS scores (Bhakta, Cozens,
Chamberlain, & Bamford, 2000; Hare et al., 2009; Richardson et al., 2000; Shaw et al.,
2011). Likewise, studies have concluded BoNT injections are a contributing factor to
improvements in patient’s self-assessed quality of life, pain, and hygiene (Caty,
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Detrembleur, Bleyenheuft, Deltombe, & Lejeune, 2009; Elovic et al., 2008; Lim, Koh, &
Paik, 2008). Past findings of improved clinical scores and overall quality of life have
been consistent; however, no general consensus has been agreed upon regarding
functional outcomes due to BoNT injections.
Often, studies associate improvements in clinical scores with improvements in
everyday function; however, it is difficult to make direct translations between the two
without a standard objective functional scale. Some have reported improvements in
functional outcomes, reporting patient ability to attain prespecified goals and improved
gait patterns following BoNT injections (McCrory et al., 2009; Sheean, Lannin, TurnerStokes, Rawicki, & Snow, 2010). Conversely, several studies have reported
improvements quantified by decreased muscle tone, while observing no apparent
functional benefit from the injection therapy (Bensmail, Robertson, Fermanian, & RobyBrami, 2010; Fridman et al., 2010; Turner-Stokes et al., 2010). It is possible that the
improvements seen in function are responses to first-time injections, while long-term
BoNT injections do not elicit additional improvements. More likely, the improvements
in function are due to therapy paired with the BoNT injections, using the neurotoxin as an
aide to maximize the effects of the training. These conflicting results suggest that there
are several factors that affect how any given patient will improve due to BoNT injections
(i.e. time since onset, number of injections, dose).
The minimal evidence behind BoNT effects on function with regards to dexterity,
active movement, and goal-driven movement has led some to suggest spasticity is not the
direct cause of functional deficits seen post-stroke (Stinear et al., 2007). The reason
behind the loss in function may be due to muscle weakness rather than increased muscle
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tone caused by spasticity. With BoNT injections acting to minimize contraction of the
targeted muscle, this should provide the patient opportunity to strengthen the antagonist
muscle. Perhaps weight training and other therapies in combination with BoNT
injections would provide the best functional outcomes in stroke survivors experiencing
motor deficits.
Researchers have not yet determined the root cause of spasticity. It may be a
result of increased excitability of afferent neurons from muscle fibers themselves, an
abnormal effect in processing this sensory information, or some other unknown
mechanism. As therapies to combat this excessive reflex action develop further, we
gather more insight into the effects of this spastic restraint. Brain imaging studies have
the potential to provide understanding of where the signal pathway is failing. If sufficient
signal is generated from cortical levels, it’s possible that this signal could be harnessed to
control an assistive device or exoskeleton to further support functionality.

3.1.2 Changes in Activity Patterns Corresponding to Improved Spasticity
Though the impact of BoNT therapy on functional motor outcome remains
unclear, improvements in clinical assessment following injections has been documented
consistently. An understanding of underlying neural reorganization has the potential to
further improve therapies and subsequently motor outcome following stroke. A handful
of studies have been performed to assess the effects of BoNT and release of spastic
restraint on activation patterns (Bhakta et al., 2000; Manganotti et al., 2010; Tomášová et
al., 2013; Veverka et al., 2012, 2014, 2016). Findings across these studies show
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commonalities in the effects of primary motor areas, but show wide variation in broader
motor and sensory areas impacted by the therapy.
Of these studies on task-related brain activation, most have observed only highly
functional patients that were naïve to BoNT injections prior to the beginning of the study
(Bhakta et al., 2000; Manganotti et al., 2010; Tomášová et al., 2013; Veverka et al., 2012,
2014, 2016). The present study found evidence of changes in cortical activity associated
with improved clinical assessments in patients receiving repeated injections. These
findings provide insight into how activity patterns change due to the long-term effects of
BoNT as it is traditionally prescribed in 3-4 month blocks. The primary purpose of these
repeated injections is to maintain a reduced severity of initial spastic symptoms, where
the greatest improvement is seen in earlier treatments. Just as the muscle adjusts to these
repeated injections, it would follow that cortical activity patterns would adapt
accordingly. It is possible that the plateau-trend seen in spasticity improvement could be
paralleled in activation patterns. Following a group of stroke patients undergoing BoNT
therapy for a longitudinal study would allow us to test this hypothesis.

3.1.3 Future Directions
In future studies, it would be worthwhile to follow patients from first-time
injections through several rounds of the injection therapy, ideally over a 1-year period,
including patients’ first 5 BoNT treatments. Assessments of spasticity severity (MAS),
functional outcome (WMFT, Box and Blocks), and cortical activity would be reported
directly before and 6 weeks after each injection. In addition, subjects could be recruited
into groups presenting mild, moderate, and severe symptoms of spasticity to allow for
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additional analyses on the effects of impairment level on activity patterns. The assistive
device used in the present study would be adapted to include optical fiber sensors to
measure movement throughout the task-related scans. The proposed modifications would
allow for a better understanding of the long-term longitudinal effects of BoNT on cortical
activity and how they come about.

3.2 CHANGES IN CONNECTIVITY FOLLOWING MOTOR RECOVERY
3.2.1 Functional and Effective Connectivity using Resting State and Task-Based Analysis
Further analysis of the fMRI data collected in this study has the potential to reveal
resting-state and task-related network connectivity changes associated with BoNT
therapy. Connectivity as a whole is categorized into two types—resting state and taskbased. (Friston & Büchel, 2003). Task-based data can be analyzed to determine taskbased functional connectivity or the correlations between spatially remote
neurophysiological events (Perkel, Gerstein, & Moore, 1967).
Although an ongoing debate over the use of task-based versus resting state
connectivity analyses persists, both are continually used to assess connectivity parameters
neural networks. The aim of task-related connectivity studies is to accentuate
components associated with the task (Friston et al., 1994). These tasks may include
working memory, motor movements, feedback systems, among others. Studies aimed to
address the overlap of resting state and active networks have been growing in popularity,
most of which observe high correspondence between the two (Fair et al., 2007; Fox et al.,
2005; Greicius, Krasnow, Reiss, & Menon, 2003). Smith et al. (2009) concluded all
networks utilized during a task are “continuously and dynamically active, even when at
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rest”. While the networks themselves may be active at rest and during task, it has been
shown that the strength of these networks and the strength of the connections to these
networks might be modulated with task (Cole et al., 2013). Therefore, future directions
might benefit from using both task-based and resting state analysis on these data.
Correlations identified by functional connectivity can arise from various factors,
including common stimulus inputs and synaptic connections to areas of direct activation.
Effective connectivity is another method of measuring connectivity within the brain,
which quantifies the influence one neuronal system exerts over another, giving a
direction to the connectivity measurement rather than connection strength alone (Perkel,
Gerstein, & Moore, 1967). Functional and effective connectivity are both dynamically
dependent on activity patterns; however, effective connectivity aims to separate the
shared activation response to a stimulus from those induced by synaptic connections
between two areas (Aertsen, Gerstein, Habib, & Palm, 1989). While the common inputs
from other brain areas may manifest as functional connectivity, effective connectivity
integrates a model to account for exertion over one neuronal system on another, which
acts to discount additional influence (Friston et al., 2011). Functional connectivity, in
contrast, can be used to explore several functional systems; resting state analysis—
unbiased regarding task performance and the a priori assumptions made by effective
connectivity approaches—can provide intrinsic brain connectivity (Rehme & Grefkes,
2013).
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3.2.2 Changes in Connectivity After Stroke
Network connectivity changes following stroke have been studied extensively
using both resting state and task-related approaches to compare effects of the trauma to
neurologically intact participants, noting most importantly the connection between
ipsilateral and contralateral M1 (Biswal, Zerrin Yetkin, Haughton, & Hyde, 1995).
Grefkes et al. (2008) assessed resting state and task-related connectivity in subacute
stroke survivors and compared findings to that of age-matched controls. Resting state
analysis showed decreased intrinsic coupling between ipsilesional M1 and SMA and
interhemispheric connections between SMAs. Additionally, effective connectivity
related to movement of the impaired arm resulted in a decreased connection from
ipsilateral to contralateral M1s, the strength of which correlated with deficit severity
(Grefkes et al., 2008). Another study by Carter et al. (2010) assessed behavioral changes
in motor impairment and their correlation with resting state inter- and intra-hemispheric
connections to primary motor areas. Similar to the Grefkes’s group, results found the
integrity of inter-hemispheric somatomotor network connections correlated with
impairment, while their analysis focused on intra-network correlations yielded no effect
(Carter et al., 2010).
A subsequent resting-state study followed acute stroke patients, concluding on
longitudinal effects in functional connectivity based on results at 0, 1, 3, and 6 months
post-stroke (Park et al., 2011). The group verified the reduced connection between
ipsilesional and contralesional M1, showing the greatest deficit 1 month following the
stroke. Additionally, increases in activity of the ipsilesional M1 with the cerebellum,
thalamus, middle frontal gyrus, and posterior parietal cortex were documented. Another
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study assessing functional connectivity in acute recovery administered resting-state
fMRIs at < 24 hours, 7 days, and 90 days after onset in participants with and without
motor deficits (Golestani, Tymchuk, Demchuk, & Goodyear, 2013). Significant
decreases in connectivity inter-hemispheric M1s were seen within 24 hours in patients
exhibiting motor impairments. Unlike previous studies, these results demonstrated that
inter-hemispheric deficits between motor areas are not affected by deficits outside of
motor ability. Following several other verifying studies, a general pattern of reduced
connectivity between interhemispheric cortical motor areas has been accepted. These
results are promising in predicting motor recovery following stroke, with implications for
improving rehabilitation methods to promote the strengthening of these network
connections.

3.2.3 Changes in Connectivity Following Therapeutic Intervention
Using the foundational knowledge of functional network connectivity following
stroke, steps were taken to assess the effects of rehabilitation. James et al. (2009)
presented results regarding acute stroke patients and the effects of a 3-week upper
extremity rehabilitation program on connectivity. All participants showed improvements
following therapy along with increased effective connectivity of the affected premotor
cortex on unaffected premotor areas (James et al., 2009). A follow-up study assessed
changes in the connectivity among primary, supplementary, and premotor areas during
imagined and executed motor tasks following mental practice and 60 hours of physical
therapy. The intervention showed improvements in regional connectivity among motor
areas during both tasks (Bajaj, Butler, Drake, & Dhamala, 2015).
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An additional study looked into the patterns resting state functional connectivity
of the primary motor cortex of the affected hemisphere after four weeks of robot-assisted
bilateral arm therapy (Fan et al., 2015). This study found increases in connections
between ipsilateral and contralateral M1 following intervention, the magnitude of which
correlated with motor and functional recovery. Similarly, Li et al. (2017) recently
assessed the effects of conventional antiplatelet aggregation drug treatments with and
without additional acupuncture therapy (conventional group and acupuncture group) on
resting state connectivity. Compared to the conventional group, acupuncture patients
showed increased functional connectivity between contralesional and ipsilesional motor
regions. In all patients, a correlation between improvements in neurological deficit and
functional connectivity between bilateral M1s was found (Li et al., 2017). These findings
regarding rehabilitation techniques consistently find increases in the connection between
interhemispheric motor areas, particularly in the primary motor cortex. Results show a
neuroplastic effect influenced by all different therapies, suggesting that functional and
effective connectivity may serve as a biomarker for recovery following stroke.
Although connectivity analysis has not been documented regarding BoNT
injections neither as a standalone therapy nor in combination with other physical therapy
methods, it could produce the same effects on M1-to-M1 connectivity as seen in previous
studies. There is also reason to believe underlying connectivity differences exists based
on the functional segregation in activity patterns seen in the present study. We might
expect that global networks related with the task would increase following BoNT
intervention, provided the increase in activity of high-order motor areas and their link to
M1 in motor planning pathways.
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3.3 TEMPORARY NERVE BLOCKS
In addition to BoNT injections, phenol nerve blocks are a peripheral method for
reducing spasticity. The blocks have shown to be effective in improving range of motion
in joints limited by muscle contracture, alleviating painful spasms, and allowing for
strengthening in antagonists of blocked (Copp, Harris, & Keenan, 1970; Keenan, 1988;
Khalili & Betts, 1967). Phenol nerve blocks show immediate onset of action, which
requires patients to adapt quickly; when administered to lower extremities, this may
interfere with gait (Bakheit, 2012). In addition, long-term use of phenol nerve blocks
could lead to permanent sensory loss (Botte, Abrams, & Bodine-Fowler, 1995). These
indicate two primary reasons why BoNT injections have become the more prevalent
peripheral intervention.
Though BoNT remains the primary protocol for focal spastic intervention, phenol
nerve blocks could provide additional information to help understand how these local
anesthetics impact cortical activity. Due to the peripheral nerve block’s immediate effect,
physicians may be able to determine how a patient may react to BoNT injections that
utilize similar inhibition methods to prevent muscle contraction. It would be beneficial to
perform fMRI and clinical (MAS) as well as functional (FMA, Wolf Motor Function
Test, Box and Blocks Test, etc.) assessments before injection of the peripheral nerve
block and again shortly after administering the block. This would allow a better
understanding of how peripheral treatment methods work to alter brain activity.
Hypothetically, if increases in range of movement elicited no change in activation
patterns, differences seen over time due to BoNT injections are likely due to neuroplastic
effects caused by gradually practicing movements with the newly improved limb.
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Likewise, if significant changes are indeed elicited by the sudden improvement in motor
ability following peripheral nerve blocks, it is likely the increased magnitude of motor
movement that causes undamaged areas involved in motor movement to become more or
less engaged.

3.4 IMPLICATIONS OF FMRI IN CLINICAL APPLICATIONS
FMRI is but one of several functional imaging modalities. The technique depends
upon blood oxygenation levels (BOLD signal) related to metabolic action during
cognitive exertion. Other methods use electrical activity, magnetic fluctuations, or
positron emitting isotopes to quantify functional activity. Using fMRI in clinical
applications provides several advantages over other approaches; high spatial resolution,
ability to observe neuronal activity in deep brain structures, no radiation, and noninvasive
administration are a few major benefits. An understanding of the pathophysiology
associated with any diseased population is essential to determine proper rehabilitation
methods.
Several years of research utilizing fMRI has led to the identification of functional
activity and connectivity patterns associated with different diseases of the brain. The
understanding of how neural activity is affected following traumatic brain injury is
valuable in designing therapies to combat debilitating consequences. Furthermore, fMRI
technology has proven beneficial in assessing the effects of therapies, providing more
information of underlying effects on the central nervous system; this knowledge is useful
for improving therapies to achieve optimal results.
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Both activation and connectivity studies have produced informative correlations
with motor ability. In fMRI activity studies, impairment severity has been related to
contralesional motor recruitment; following therapeutic interventions, those that show
improvements in motor assessment have decreased contralesional activation and
increased activity in ipsilesional primary motor areas. This trend is translated to
connectivity results, with patients demonstrating increased connectivity between
interhemispheric motor areas. Therapeutic interventions can be developed or revised to
target this connection, focusing on neurorehabilitation tactics to exercise these regions
and strengthen associated networks.
As studies investigating the effects of BoNT injection therapy progress, we will
gain a better understanding of the causal relationship between improved motor
movements and changes in neuronal activity. Exploration of other peripheral therapies in
focal spasticity management may determine the origin of the motor impairment so often
experienced by stroke survivors. Clarification will guide therapies to focus on either
peripheral or central approaches to the problem. A major question remains unanswered:
Does focal spasticity stem from cortical signal suppression or the muscles inability to
respond to the signal? Further investigation using fMRI technology could hold the key to
the answer, providing a doorway to new and improved rehabilitation methods.
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APPENDICES

APPENDIX A: Statistical Analysis of BOLD Signal

Figure A1: Diagram of Statistical Analysis Pipeline.
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APPENDIX B: Fugl-Meyer Scoring Breakdown
Items are scored on a 3-point ordinal scale:
0 = cannot perform
1 = performs partially
2 = performs fully
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APPENDIX C: BoNT Doses and Locations
Patient No.
BTX 1

Muscle
Pec Major (2 sites)
Pec Minor (1 site)
Latisimus Dorsi (3 sites)
Triceps (3 sites)
Brachialis (3 sites)
Brachioradialis (1 site)
ECR (1 site)
FCR (1 site)
FDP (1 site)
FDL (1 site)

Dilution
2:1
2:1
2:1
2:1
2:1
2:1
2:1
2:1
2:1
2:1

Dosage
50 units
50 units
50 units
75 units
75 units
25 units
25 units
20 units
30 units
50 units

BTX2

R SC (1 site)
Pec Major (3 sites)
Brachialis (3 sites)
Brachioradialis (2 sites)
Pron Teres (2 sites)
FCR (1 site)
FCU (1 site)
FDS (1 site)
FDP (1 site)
FPL (1 site)

4:1
4:1
4:1
4:1
4:1
4:1
4:1
4:1
4:1
4:1

25 units
75 units
75 units
25 units
25 units
25 units
25 units
25 units
25 units
25 units

BTX3

Biceps Brachii (2 sites)
Brachioradialis (1 site)
Pron Teres (1 site)
FCR (2 sites)
FCU (2 sites)
FDS (2 sites)
FDP (2 sites)

4:1
4:1
4:1
2:1
2:1
4:1
4:1

50 units
25 units
25 units
50 units
50 units
50 units
50 units

BTX4

Pec Major (4 sites)
Lat Dorsi (2 sites)
Pron Teres (2 sites)
FDS (1 site)
FDP (1 site)

2cc:500u
2cc:500u
2cc:500u
2cc:500u
2cc:500u

200 units
100 units
100 units
75 units
75 units
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BTX5

Pec Major
Biceps Brachii
FDS, Digit 2
FDS, Digit 3
FDS, Digit 4
FDS, Digit 5
Biceps Femoris
Semimem
Semitend

?
?
?
?
?
?
?
?
?

75 units
25 units
25 units
25 units
25 units
25 units
100 units
50 units
50 units

BTX6

Lev Scap (1 site)
Lat Dorsi (8 sites)
Lateral Scap CT (10 sites)
Pec Minor (2 sites)
Pron Teres (1 site)
ECR (1 site)
FPB (1 site)

4:1
8:1
8:1
4:1
4:1
4:1
4:1

25 units
75 units
25 units
25 units
10 units
15 units
10 units

BTX7

Vastus Lat (2 sites)
Lat Hamstring (2 sites)
Med Hamstring (3 sites)
Med Gastroc (2 sites)
Lat Gastroc (2 sites)
Lat Dorsi (2 sites)
Brachialis (2 sites)
Brachioradialis (1 site)

2:1
2:1
2:1
2:1
2:1
2:1
2:1
2:1

50 units
50 units
75 units
50 units
50 units
50 units
50 units
25 units

BTX8

Lat Dorsi (2 sites)
Brachialis (2 sites)
Brachioradialis (1 site)
FCR (1 site)
FCU (1 site)
FDS (2 sites)
FDP (2 sites)
FPL (1 site)
FPB (1 site)
Lumbricals (3 sites)
Vastus Lat (4 sites)

4:1
4:1
4:1
4:1
4:1
4:1
4:1
4:1
4:1
4:1
4:1

50 units
30 units
20 units
25 units
25 units
50 units
50 units
25 units
25 units
25 units
100 units
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BTX9

Pec Major (2 sites)
Brachialis (3 sites)
Brachioradialis (1 site)
Pron Teres (1 site)
ECR (1 site)
ECU (1 site)
FDS (1 site)
FDP (1 site)
FPB (1 site)
Lumbricals (4 sites)

2:1
2:1
2:1
2:1
2:1
2:1
2:1
2:1
2:1
2:1

25 units
75 units
25 units
25 units
25 units
25 units
25 units
25 units
25 units
50 units
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APPENDIX D: Individual Participant Activity Maps

Figure D1: Individual activity map for participant BTX 1 at W0. The mean BOLD
activity is shown in red and yellow areas to indicate activity corresponding with the task.
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Figure D2: Individual activity map for participant BTX 1 at W6. The mean BOLD
activity is shown in red and yellow areas to indicate activity corresponding with the task.

Figure D3: Individual activity map for participant BTX 2 at W0. The mean BOLD
activity is shown in red and yellow areas to indicate activity corresponding with the task.
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Figure D4: Individual activity map for participant BTX 2 at W6. The mean BOLD
activity is shown in red and yellow areas to indicate activity corresponding with the task.

Figure D5: Individual activity map for participant BTX 3 at W0. The mean BOLD
activity is shown in red and yellow areas to indicate activity corresponding with the task.
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Figure D6: Individual activity map for participant BTX 3 at W6. The mean BOLD
activity is shown in red and yellow areas to indicate activity corresponding with the task.

Figure D7: Individual activity map for participant BTX 4 at W0. The mean BOLD
activity is shown in red and yellow areas to indicate activity corresponding with the task.
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Figure D8: Individual activity map for participant BTX 4 at W6. The mean BOLD
activity is shown in red and yellow areas to indicate activity corresponding with the task.

Figure D9: Individual activity map for participant BTX 5 at W0. The mean BOLD
activity is shown in red and yellow areas to indicate activity corresponding with the task.
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Figure D10: Individual activity map for participant BTX 5 at W6. The mean BOLD
activity is shown in red and yellow areas to indicate activity corresponding with the task.

Figure D11: Individual activity map for participant BTX 6 at W0. The mean BOLD
activity is shown in red and yellow areas to indicate activity corresponding with the task.
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Figure D12: Individual activity map for participant BTX 6 at W6. The mean BOLD
activity is shown in red and yellow areas to indicate activity corresponding with the task.

Figure D13: Individual activity map for participant BTX 7 at W0. The mean BOLD
activity is shown in red and yellow areas to indicate activity corresponding with the task.

97

Figure D14: Individual activity map for participant BTX 7 at W6. The mean BOLD
activity is shown in red and yellow areas to indicate activity corresponding with the task.

Figure D15: Individual activity map for participant BTX 8 at W0. The mean BOLD
activity is shown in red and yellow areas to indicate activity corresponding with the task.
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Figure D16: Individual activity map for participant BTX 8 at W6. The mean BOLD
activity is shown in red and yellow areas to indicate activity corresponding with the task.

Figure D17: Individual activity map for participant BTX 9 at W0. The mean BOLD
activity is shown in red and yellow areas to indicate activity corresponding with the task.
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Figure D18: Individual activity map for participant BTX 9 at W6. The mean BOLD
activity is shown in red and yellow areas to indicate activity corresponding with the task.
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Figure D19: Individual activity map for participant C1 at W6. The mean BOLD
activity is shown in red and yellow areas to indicate activity corresponding with the task.

Figure D20: Individual activity map for participant C2 at W0. The mean BOLD
activity is shown in red and yellow areas to indicate activity corresponding with the task.
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Figure D21: Individual activity map for participant C2 at W6. The mean BOLD
activity is shown in red and yellow areas to indicate activity corresponding with the task.

Figure D22: Individual activity map for participant C3 at W0. The mean BOLD
activity is shown in red and yellow areas to indicate activity corresponding with the task.
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Figure D23: Individual activity map for participant C3 at W6. The mean BOLD
activity is shown in red and yellow areas to indicate activity corresponding with the task.

Figure D24: Individual activity map for participant C4 at W0. The mean BOLD
activity is shown in red and yellow areas to indicate activity corresponding with the task.
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Figure D25: Individual activity map for participant C4 at W6. The mean BOLD
activity is shown in red and yellow areas to indicate activity corresponding with the task.

Figure D26: Individual activity map for participant C5 at W0. The mean BOLD
activity is shown in red and yellow areas to indicate activity corresponding with the task.
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Figure D27: Individual activity map for participant C6 at W0. The mean BOLD
activity is shown in red and yellow areas to indicate activity corresponding with the task.

Figure D28: Individual activity map for participant C6 at W6. The mean BOLD
activity is shown in red and yellow areas to indicate activity corresponding with the task.
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Figure D29: Individual activity map for participant C7 at W0. The mean BOLD
activity is shown in red and yellow areas to indicate activity corresponding with the task.

Figure D30: Individual activity map for participant C7 at W6. The mean BOLD
activity is shown in red and yellow areas to indicate activity corresponding with the task.
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Figure D31: Individual activity map for participant C8 at W0. The mean BOLD
activity is shown in red and yellow areas to indicate activity corresponding with the task.

Figure D32: Individual activity map for participant C8 at W6. The mean BOLD
activity is shown in red and yellow areas to indicate activity corresponding with the task.
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Figure D33: Individual activity map for participant C9 at W0. The mean BOLD
activity is shown in red and yellow areas to indicate activity corresponding with the task.

Figure D34: Individual activity map for participant C9 at W6. The mean BOLD
activity is shown in red and yellow areas to indicate activity corresponding with the task.
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APPENDIX E: Lesion Correction Results
Neuronal activity was assessed by utilizing statistical maps to indicate areas of
correlation with the hemodynamic response. FMRI analyses were carried out using FSL’s
fMRI Expert Analysis Tool (FEAT) as mentioned in the Methods section of Chapter 2,
with additional steps taken to remove lesioned areas from the statistical analysis. To
determine the group level activity maps, all lesioned voxels were identified for all
individual participants. At each voxel, a list of all participants with non-lesioned brain
matter is created and stored. For all voxels, all unique combinations are counted and
recorded. The FEAT analysis is performed for all combinations, to ensure no lesioned
brain areas will impact the final group map results. At every voxel, the combination is
read and the corresponding z-statistic is pulled from the same voxel in that combination’s
FEAT run. This method produced final z-statistic maps that include only participants
with non-lesioned brain matter in any given voxel.
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Figure E1: Lesion-Corrected Group Activity Maps of Stroke Participants at W0.
Each panel shows axial slices of the MNI template overlaid with z-statistic maps of the
averaged stroke group before BoNT injection while accounting for lesion location.
Activity maps indicate volumes in which there was significant (p < 0.05) levels of
activity across the group. The right side of the brain is displayed on the left.
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Figure E2: Lesion-Corrected Group Activity Maps of Stroke Participants at W6.
Each panel shows axial slices of the MNI template overlaid with z-statistic maps of the
averaged stroke group after BoNT injection while accounting for lesion location. Activity
maps indicate volumes in which there was significant (p < 0.05) levels of activity across
the group. The right side of the brain is displayed on the left.
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Figure E3: Lesion Corrected Contrast between Stroke Participants Before and
After BoNT Intervention. Significantly activated voxels (Z > 2.3, p < 0.05) are overlaid
on a standard MNI brain (a), illustrating areas that showed a significant increase in
activity following the BoNT intervention. These active areas were observed in three
clusters (b) indicated by red, blue, and green volumes.

